Shenzhen YHLO Biotech Co., Ltd.

688575

CNE100005204

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 15/01/2026			5-day change	1st Jan Change
15.38 ^CNY	-1.35%		-2.72%	+8.31%

01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT

Shenzhen YHLO Biotech Co., Ltd. announces Annual dividend, payable on June 27, 2025

Published on 04/24/2025

S&P Capital IQ

Shenzhen YHLO Biotech Co., Ltd.

-1.35%

Shenzhen YHLO Biotech Co., Ltd. announced Annual dividend of CNY 0.2100 per share payable on June 27, 2025, ex-date on June 27, 2025 and record date on June 26, 2025.

Latest news about Shenzhen YHLO Biotech Co., Ltd.

01-07	YHLO Biotech Discloses 'Uncertainty' Stemming From Recent Partnership With Brain-Machine Starlink	MT
12-24	Shenzhen YHLO Biotech Subsidiary Gets Chinese Provincial-Level Approval for Two Diagnostic Kits	MT
12-16	Shenzhen YHLO Biotech Gets Chinese Provincial Regulator's Approval for Two Autoimmune Disease Testing Kits	MT
11-28	YHLO Biotech Gets Dutch Certification for HIV Kit	MT
11-26	YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer	MT
11-20	Shenzhen YHLO Biotech Gets Guangdong Approval for Immunoassay Analyzer	MT
11-18	Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit	MT
11-07	YHLO Biotech Gets Registration Certificate for Human Chorionic Gonadotropin Kit	MT
29/10/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
11/09/25	YHLO Biotech's Controlling Shareholder Trims Stake	MT
25/08/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Shenzhen YHLO Biotech's shareholders to unload shares	RE
26/05/25	Declaration of Voting Results by Shenzhen YHLO Biotech	CI
17/05/25	Certain A Shares of Shenzhen YHLO Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 17-MAY-2025.	CI
15/05/25	Shenzhen YHLO Biotech Receives Shareholder Proposal from Kunhui Hu	CI
24/04/25	Shenzhen YHLO Biotech Co., Ltd. announces Annual dividend, payable on June 27, 2025	CI
24/04/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
17/03/25	Shenzhen YHLO Biotech Gets China Copyright Nod for Diabetes Diagnosis Software	MT
27/02/25	Shenzhen YHLO Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
12/02/25	YHLO Biotech Gets Registration Certificates for Two Assay Kits	MT
11/02/25	Shenzhen YHLO Biotech Gets Medical Device Registration for Two Assay Kits	MT
20/01/25	YHLO Biotech's Calcitonin Kit Gets Medical Device Registration Certificate	MT
13/01/25	Shenzhen YHLO Biotech Gets Local Approval for Ovarian, Bone Disease Testing Kits	MT
17/12/24	Shenzhen YHLO Biotech Elects Chair, Vice Chair	MT
02/12/24	Shenzhen YHLO Biotech Gets Medical Device Registration for Hormone Assay Kit	MT

Chart Shenzhen YHLO Biotech Co., Ltd.

Duration

Period

688575: Dynamic Chart

Shenzhen YHLO Biotech Co Ltd is a China-based company principally engaged in the research and development, manufacture and sales of in-vitro diagnostic equipment and supporting reagents, as well as the agency sales of some non-self-produced medical device products. The Company's products are applied in autoimmunity, reproductive health, diabetes and infectious disease fields. The Company's main products include in-vitro diagnostic instruments and supporting reagents based on chemiluminescence, immunoblotting, enzyme-linked immunoassay, immunofluorescence chromatography and other methodologies. The Company distributes its products in domestic market and to overseas markets.

Employees

1,678

Sector

Medical Equipment, Supplies & Distribution

Calendar

04-26 - Q1 2026 Earnings Release (Projected)

More about the company